The Journal of Thoracic and Cardiovascular Surgery
Volume 133, Issue 6 , Pages 1573-1580.e2 , June 2007

Results of a multicenter clinical trial with the Thoratec Implantable Ventricular Assist Device

  • Mark S. Slaughter, MD

      Affiliations

    • Advocate Christ Medical Center, Oak Lawn, Ill
    • Corresponding Author InformationAddress for reprints: Mark Slaughter, MD, Advocate Christ Medical Center, 4440 W 95th St, Suite 205, Oak Lawn, Il 60453.
  • ,
  • Steven S. Tsui, MD

      Affiliations

    • Papworth Hospital, Cambridge, UK
    • S.S.T. reports consulting and lecture fees and grant support from Ventracor (UK) Pty Ltd.
  • ,
  • Aly El-Banayosy, MD

      Affiliations

    • Heart Center NRW, Bad Oeynhausen, Germany
    • A.E-B. reports consulting fees from World-Heart.
  • ,
  • Benjamin C. Sun, MD

      Affiliations

    • Ohio State University, Columbus, Ohio
    • B.S. reports consulting and lecture fees from Thoratec Corporation and lecture fees from and equity ownership in ABIOMED, Inc.
  • ,
  • Robert L. Kormos, MD

      Affiliations

    • University of Pittsburgh Medical Center, Pittsburgh, Pa
    • R.L.K. reports fellowship support from Thoratec Corporation.
  • ,
  • Dale K. Mueller, MD

      Affiliations

    • OSF St Francis Medical Center, Peoria, Ill
  • ,
  • H. Todd Massey, MD

      Affiliations

    • University of Rochester, Rochester, NY
  • ,
  • Timothy B. Icenogle, MD

      Affiliations

    • Sacred Heart Medical Center, Spokane, Wash
    • T.B.I. reports lecture fees from Thoratec Corporation.
  • ,
  • David J. Farrar, PhD

      Affiliations

    • Thoratec Corporation, Pleasanton, Calif
    • D.J.F. reports employment by and equity ownership in Thoratec Corporation.
  • ,
  • J. Donald Hill, MD

      Affiliations

    • University of California Medical Center, San Francisco, Calif.
    • J.D.H. reports consulting fees from and equity ownership in Thoratec Corporation.
  • ,
  • IVAD Study Group

Received 31 August 2006 ,Revised 6 December 2006 ,Accepted 12 December 2006.

  • Image Result

    Implantable ventricular assist device has same internal flow path as paracorporeal ventricular assist device, but plastic housing is replaced with smooth, contoured, polished titanium housing for impr

    Implantable ventricular assist device has same internal flow path as paracorporeal ventricular assist device, but plastic housing is replaced with smooth, contoured, polished titanium housing for improved implantability, and driveline is extended and covered with polyester velour as percutaneous lead.

  • Image Result
    Implantable ventricular assist device is placed in preperitoneal position and is small enough to be used for univentricular (A) or biventricular (B) support. One percutaneous pneumatic driveline is tu

    Implantable ventricular assist device is placed in preperitoneal position and is small enough to be used for univentricular (A) or biventricular (B) support. One percutaneous pneumatic driveline is tunneled for each ventricular assist device.

PII: S0022-5223(07)00058-X

doi: 10.1016/j.jtcvs.2006.11.050

The Journal of Thoracic and Cardiovascular Surgery
Volume 133, Issue 6 , Pages 1573-1580.e2 , June 2007